Search for: "Mylan Pharmaceuticals"
Results 701 - 720
of 739
Sort by Relevance
|
Sort by Date
28 Mar 2008, 6:00 am
- Anonymity of policy research group quoted on pharma patenting policy and stats: (Spicy IP),Thailand: More news/reactions on compulsory licenses: (Generic Pharmaceuticals & IP),US: Follow-on biologic drugs and patent law: A potential disconnect? [read post]
24 Mar 2008, 5:09 am
We don't usually report on labor and employment cases in this space.Heck, we don't usually read labor and employment cases.But the recent decision in Mylan Pharmaceuticals , Inc. v. [read post]
11 Mar 2008, 12:29 pm
Zaring mentions the case in which the hedge fund Perry Corp. used derivatives to hedge its interest in King Pharmaceuticals. [read post]
11 Mar 2008, 5:36 am
Ever since an investor in Mylan acquired sufficient hedged shares from investment banks to tip the vote in favor of a merger with King Pharmaceuticals - in essence, using votes that were untethered to the economic stakes of the firm to force that firm into an acquisition - there has been a renewed interest in corporate voting. [read post]
22 Feb 2008, 6:00 pm
), (Washington State Patent Law Blog), (The IP Factor), (IPBiz), (IP Spotlight), (IP Law360), (Innovationpartners), (IPBiz),US FTC files complaint against Cephalon alleging the company paid four generic drug manufacturers (Ranbaxy, Teva, Mylan and Barr) to delay entry as part of litigation settlements: (IP Law360), (IP Law360), (Spicy IP),GlobalGlobal - GeneralWhat is IP value all about? [read post]
7 Feb 2008, 10:46 am
Ok, we've worried about what might happen if our side (the defense, for any new readers) were to lose the preemption wars currently in progress before the Supreme Court. [read post]
7 Feb 2008, 9:00 am
On June 1, 2005, after a jury trial lasting over three weeks, a jury found for Blue Cross Blue Shield of Massachusetts (“BCBS-MA”), Blue Cross Blue Shield of Minnesota (“BCBS-MN”), Federated Mutual Insurance Company (“Federated”), and Health Care Service Corporation (“HCSC”) (collectively “Plaintiffs”) against Mylan Laboratories Inc. and Mylan Pharmaceuticals Inc., Cambrex… [read post]
7 Jan 2008, 8:48 pm
Mylan Pharmaceuticals Inc. 1:07-cv-00177; filed December 28, 2007 in the Northern District of... [read post]
5 Jan 2008, 6:00 am
You can separately subscribe to the IP Think Tank Global week in Review at [feeds.feedburner.com]GlobalComing out of copyright - some notable deaths from 1937: (IPKat),Design patents: No longer the province of individual inventors: (Patently O),Fail fast, ready fire aim and Stanford v Cal: (IP Think Tank),Walls, Alexander the Great and Partha Bose: (IP Think Tank),A fair use primer for online content creators: (Ars Technica)ISO moves to create global… [read post]
23 Dec 2007, 8:00 pm
You can separately subscribe to the IP Thinktank Global week in Review at [feeds.feedburner.com]GlobalEvents in Bali heap further pressure on all IP owners: (IAM),Velcro defies generic claim in domain name battle: (OUT-LAW),ICANN forms group to hasten non-English domain names: (IP Justice)WTO members continue debate on geographical indications register: (Intellectual Property Watch),Creative Commons launches CCo and CC programs: (World IP Day),Green IP Strategy - risks… [read post]
10 Nov 2007, 9:26 pm
Mylan is the first ANDA filer for a generic version of Paxil CR. [read post]
8 Nov 2007, 9:00 pm
Due to popular demand, I will have a separate section for Pharmaceutical Industry items from this week. [read post]
26 Oct 2007, 1:00 am
Paroxetine - Mylan enters into a patent license and settlement with GlaxoSmithKline (GSK) relating to Paroxetine Hydrochloride (HCl) Extended-release (ER) Tablets (Phillip Brooks), (IP Law360), The perils of not registering copyright in the USA - Seeking only minimal recognition for his Baltimore Ravens logo design, Baltimore amateur artist ends up seeking certiori from the Supreme Court in his copyright infringement case, winds up with no damages award (Maryland IP Law Blog), Amgen's… [read post]
17 Oct 2007, 10:00 pm
I have just found out from the Generic Pharmaceuticals and IP blog that Teva has now sued 16 companies in relation to its Carvedilol process patents.The 16 defendants are: Zentiva; Mylan; Taro Pharmaceuticals; Lupin; Moehs Iberica; Urquima; Orchid; Wanbury;Z hejiang Huahai; USV Ltd.; Cadila; Ranbaxy; Dr. [read post]
22 Aug 2007, 4:50 am
First, he "allowed Mylan to enter into the exclusive supply agreement with Profarmaco/GYMA [who were to supply Mylan with the "active pharmaceutical ingredients" for lorazepam and clorazepate for the generic versions of the drugs on an exclusive basis] without fully investigating the issues or apprising Mylan of the substantial risks. [read post]
7 Jul 2007, 9:36 pm
Until June 22, when FDA delisted Pfizer's patent, Mylan and Apotex had the only approved ANDAs for generic Norvasc. [read post]
3 Jul 2007, 10:47 am
Mylan Labs., 417 F. [read post]
28 Jun 2007, 10:16 am
Although it is doubtful that the Prohias litigation will ever get anywhere near class certification, these plaintiffs' conduct demonstrates the individualized nature of the inquiry, even in stripped-down consumer fraud litigation.From our perspective Prohias II, gets into even jucier defenses, since it's more specific to the pharmaceutical industry. [read post]
26 Jun 2007, 3:27 am
According to the Houston Chronicle, Texas is suing three drug companies alleging the companies took advantage of the Medicare system and cost the state tens of millions of dollars in overpayments.The lawsuit was filed against Sandoz, Inc. of New Jersey, Mylan Laboratories of Pennsylvania and Teva Pharmaceuticals, Inc., along with some of their subsidiaries. [read post]
16 Jun 2007, 7:17 am
Mylan Laboratories Inc., Mylan Pharmaceuticals Inc. and UDL Laboratories Inc. v. [read post]
